Interojo Co

Interojo Co Operating Expenses

The Total Operating Expenses of Interojo Co (119610.KQ) as of Nov 20, 2026 is 15.39 B KRW. In the previous year, Total Operating Expenses was 18.01 B KRW — a change of -14.54% (lower).

Operating Expenses

15.39 BKRW

YoY

-14.54%

Last updated:

Total Operating Expenses of Interojo Co is 2025 15.39 B KRW. Total Operating Expenses of Interojo Co was 2024 18.01 B KRW. It decreases by -14.54% lower compared to the previous year.

The Interojo Co Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
24.41 B KRW
Jan 1, 2019
24.52 B KRW
Jan 1, 2020
28.15 B KRW
Jan 1, 2021
27.32 B KRW
Jan 1, 2022
27.98 B KRW
Jan 1, 2023
17.91 B KRW
Jan 1, 2024
18.01 B KRW
Jan 1, 2025
15.39 B KRW
The Interojo Co Operating Expenses history
YEAROperating ExpensesYoY
15.39 BKRW-14.54%
18.01 BKRW+0.57%
17.91 BKRW-36.00%
27.98 BKRW+2.41%
27.32 BKRW-2.97%
28.15 BKRW+14.80%
24.52 BKRW+0.45%
24.41 BKRW+10.94%
22.01 BKRW+13.43%
19.40 BKRW+16.73%
16.62 BKRW+6.95%
15.54 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Interojo Co Stock analysis

What does Interojo Co do? Interojo Co Ltd manufactures and sells contact lenses including silicone hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses, therapy and bandage lenses, and rigid gas permeable (RGP) contact lenses along with solutions. The company distributes its products in domestic and overseas markets, targeting both retail consumers and healthcare providers who purchase lenses for patient use. Its product range caters to diverse vision correction needs, from standard to specialized medical applications, with solutions supporting lens care and usage. The firm's primary revenue streams come from the sale of contact lenses and associated solutions to customers in both domestic and international markets. Products like silicone hydrogel lenses and RGP contact lenses represent key offerings for everyday wear and specialized vision correction, while therapy and bandage lenses serve medical applications requiring professional oversight. The company's domestic market presence complements its overseas distribution, ensuring broad accessibility across different customer segments. Interojo Co Ltd's business model focuses on direct sales of its comprehensive product portfolio to end-users and healthcare institutions. The company's product lines address various vision correction scenarios, from routine daily use with frequent replacement lenses to advanced medical needs with therapy lenses. By maintaining a diverse range of contact lenses and solutions, the company serves both consumer and professional markets without relying on third-party partnerships or additional services. Interojo Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Interojo Co stock

Total Operating Expenses of Interojo Co is 15.39 B KRW in 2025.

Total Operating Expenses of Interojo Co changed from 18.01 B KRW to 15.39 B KRW, representing a -14.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Interojo Co since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Interojo Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Interojo Co

All Key Metrics — Interojo Co